EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.17.23 | medicine | ACE2 may be a target for therapeutic interventions that aim to reduce albuminuria and glomerular injury | Mus musculus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.17.23 | MLN-4760 | - |
Mus musculus | |
3.4.17.23 | telmisartan | specific angiotensin II type 1 receptor blocker | Mus musculus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.4.17.23 | membrane | - |
Mus musculus | 16020 | - |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.17.23 | Mus musculus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.17.23 | glomerulus | - |
Mus musculus | - |
3.4.17.23 | kidney | ACE and ACE2 co-localized strongly in the apical brush border of the proximal tubule | Mus musculus | - |
3.4.17.23 | podocyte | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.17.23 | angiotensin II + H2O | - |
Mus musculus | angiotensin-(1-7) + Phe | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.17.23 | ACE2 | - |
Mus musculus |